Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
1,328
Views
1
CrossRef citations to date
0
Altmetric
Coronavirus – Case Report

SARS-CoV-2 evolution in a patient with secondary B-cell immunodeficiency: A clinical case

Olgo A. Mukhinaa Moscow Healthcare Department, State Budgetary Healthcare Institution City Clinical Hospital, Moscow, RussiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3794-4991View further author information
ORCID Icon,
Daria S. Fominaa Moscow Healthcare Department, State Budgetary Healthcare Institution City Clinical Hospital, Moscow, Russia;b Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation, Sechenov University, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0002-5083-6637View further author information
ORCID Icon,
Vasiliy V. Parshina Moscow Healthcare Department, State Budgetary Healthcare Institution City Clinical Hospital, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0003-3783-3412View further author information
ORCID Icon,
Vladimir A. Gushchinc Federal State Budgetary Institution “National Research Center for Epidemiology and Microbiology named after Honorary Academician N.-F. Gamaleya” of the Ministry of Health of the Russian Federation, Moscow, Russia;d Department of Virology, Faculty of Biology, Lomonosov Moscow State University, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0002-9397-3762View further author information
ORCID Icon,
Inna V. Dolzhikovac Federal State Budgetary Institution “National Research Center for Epidemiology and Microbiology named after Honorary Academician N.-F. Gamaleya” of the Ministry of Health of the Russian Federation, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0003-2548-6142View further author information
ORCID Icon,
Alexey M. Shchetininc Federal State Budgetary Institution “National Research Center for Epidemiology and Microbiology named after Honorary Academician N.-F. Gamaleya” of the Ministry of Health of the Russian Federation, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0003-1842-3899View further author information
ORCID Icon,
Dmitriy M. Chudakove Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia;f Pirogov Russian National Research Medical University, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0003-0430-790XView further author information
ORCID Icon,
Evgeniia Alekseevae Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0002-4510-559XView further author information
ORCID Icon,
Dmitriy Korostinf Pirogov Russian National Research Medical University, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0003-1343-2550View further author information
ORCID Icon,
Georgii A. Bazykine Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia;g Institute for Information Transmission Problems of the Russian Academy of Sciences (Kharkevich Institute), Moscow, RussiaORCID Iconhttps://orcid.org/0000-0003-2334-2751View further author information
ORCID Icon,
Galya Klinkg Institute for Information Transmission Problems of the Russian Academy of Sciences (Kharkevich Institute), Moscow, RussiaORCID Iconhttps://orcid.org/0000-0001-8466-6958View further author information
ORCID Icon,
Denis Yu. Logunovc Federal State Budgetary Institution “National Research Center for Epidemiology and Microbiology named after Honorary Academician N.-F. Gamaleya” of the Ministry of Health of the Russian Federation, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0003-4035-6581View further author information
ORCID Icon &
Maryana A. Lysenkoa Moscow Healthcare Department, State Budgetary Healthcare Institution City Clinical Hospital, Moscow, Russia;f Pirogov Russian National Research Medical University, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0001-6010-7975View further author information
ORCID Icon show all
Article: 2101334 | Received 13 Apr 2022, Accepted 09 Jul 2022, Published online: 01 Aug 2022

References

  • Han Z, Battaglia F, Terlecky SR. Discharged COVID-19 patients testing positive again for SARS-CoV-2 RNA: a minireview of published studies from China. J Med Virol. 2021;93(1):1–5. doi:10.1002/jmv.26250.
  • Dao TL, Hoang VT, Gautret P. Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review. Eur J Clin Microbiol Infect Dis. 2021;40(1):13–25. doi:10.1007/s10096-020-04088-z.
  • Ikegami S, Benirschke R, Flanagan T, Tanna N, Klein T, Elue R, Debosz P, Mallek J, Wright G, Guariglia P, Kang J. Persistence of SARS-CoV-2 nasopharyngeal swab PCR positivity in COVID-19 convalescent plasma donors. J Med Virol. 2020;92(11):2366–2367. doi:10.1002/jmv.26056.
  • Kang H, Wang Y, Tong Z, Liu X. Retest positive for SARS-CoV-2 RNA of “recovered” patients with COVID-19: persistence, sampling issues, or re-infection? J Med Virol. 2020;92(11):2263–2265. doi:10.1002/jmv.26114.
  • Stanevich O, Alekseeva E, Sergeeva M, Fadeev A, Komissarova K, Ivanova A, Simakova T, Vasilyev K, Shurygina AP, Stukova M, et al. SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19. Researchsquare. Version 1, Posted28 Jul, 2021. doi:10.21203/rs.3.rs-750741/v1.
  • Avouac J, Drumez E, Seror R, Georgin-Lavialle S, El Mahou S, Pertuiset E, Pham T, Marotte H, Servettaz A, et al. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. Lancet Rheumatol. 2021;3(6):e419–e426. doi:10.1016/S2665-9913(21)00059-X.
  • Jin H, Reed JC, Liu ST, Ho HE, Lopes JP, Ramsey NB, Waqar O, Rahman F, Aberg JA, Bouvier NM, et al. Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma. J Allergy Clin Immunol Pract. 2020;8(10):3594–3596.e3. doi:10.1016/j.jaip.2020.08.059.
  • Hueso T, Pouderoux C, Péré H, Beaumont AL, Raillon LA, Ader F, Chatenoud L, Eshagh D, Szwebel TA, Martinot M, Camou F. Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19. Blood. 2020;136(20):2290–2295. doi:10.1182/blood.2020008423.
  • Turakhia Y, Thornlow B, Hinrichs AS, De Maio N, Gozashti L, Lanfear R, Haussler D, Corbett-Detig R. Ultrafast sample placement on existing tRees (UShER) enables real-time phylogenetics for the SARS-CoV-2 pandemic. Nat Genet. 2021;53(6):809–816. doi:10.1038/s41588-021-00862-7.
  • Marty R, Kaabinejadian S, Rossell D, Slifker MJ, van de Haar J, Engin HB, de Prisco N, Ideker T, Hildebrand WH, Font-Burgada J, et al. MHC-I genotype restricts the oncogenic mutational landscape. Cell. 2017;171(6):1272–1283.e15. doi:10.1016/j.cell.2017.09.050.
  • Reynisson B, Alvarez B, Paul S, Peters B, Nielsen M. NetMhcpan-4.1 and NetMhciipan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 2020;48(W1):W449–W454. doi:10.1093/nar/gkaa379.
  • Vita R, Mahajan S, Overton JA, Dhanda SK, Martini S, Cantrell JR, Wheeler DK, Sette A, Peters B. The immune epitope database (IEDB): 2018 update. Nucleic Acids Res. 2019;47(D1):D339–D343. doi:10.1093/nar/gky1006.
  • Behloul N, Baha S, Shi R, Meng J. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein. Virus Res. 2020;286:198058. doi:10.1016/j.virusres.2020.198058.
  • Corey L, Beyrer C, Cohen MS, Michael NL, Bedford T, Rolland M. SARS-CoV-2 variants in patients with immunosuppression. N Engl J Med. 2021;385(6):562–566. PMID: 34347959; PMCID: PMC8494465. doi:10.1056/NEJMsb2104756.
  • Nyström K, Hjorth M, Fust R, Nilsdotter-Augustinsson Å, Larsson M, Niward K, Nyström S. Specific T-cell responses for guiding treatment with convalescent plasma in severe COVID-19 and humoral immunodeficiency: a case report. BMC Infect Dis. 2022;22(1):362. PMID: 35410137; PMCID: PMC8996199. doi:10.1186/s12879-022-07323-4.
  • Hueso T, Pouderoux C, Péré H, Beaumont AL, Raillon LA, Ader F, Chatenoud L, Eshagh D, Szwebel TA, Martinot M, et al. Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19. Blood. 2020;136(20):2290–2295. PMID: 32959052; PMCID: PMC7702482. doi:10.1182/blood.2020008423.
  • London J, Boutboul D, Lacombe K, Pirenne F, Heym B, Zeller V, Baudet A, Ouedrani A, Bérezné A. Severe COVID-19 in patients with B cell alymphocytosis and response to convalescent plasma therapy. J Clin Immunol. 2021;41(2):356–361. Epub 2020 Nov 20. PMID: 33219491; PMCID: PMC7678568. doi:10.1007/s10875-020-00904-5.
  • Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, Solomon IH, Kuo HH, Boucau J, Bowman K, et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med. 2020;383(23):2291–2293. Epub 2020 Nov 11. PMID: 33176080; PMCID: PMC7673303. doi:10.1056/NEJMc2031364.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.